Eva M Sevick-Muraca (Eva M Sevick)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Neoadjuvant Chemotherapy

Fluorescence Imaging

Squamous Cell Carcinoma

Sentinel Lymph Node

Top Venues

Physiological reports

Nature nanotechnology

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna R Vang, Simona F Shaitelman, John C Rasmussen, Wenyaw Chan, Eva M Sevick-Muraca, Melissa B Aldrich
Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients. Cancers 15 (3) (2023)
Di Chen, David Wiggins, Eva M Sevick-Muraca, Michael J Davis, Philip D King
An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves. bioRxiv : the preprint server for biology (2023)
Anna R Vang, Simona F Shaitelman, John C Rasmussen, Wenyaw Chan, Eva M Sevick-Muraca, Melissa B Aldrich
Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients. Cancers 15 (3) (2023)
Eva M Sevick-Muraca
Non-invasive confocal microscopy of the immune system. Nature nanotechnology 17 (6) (2022)
Carolina Mantilla-Rojas, Fred C Velasquez, Janelle E Morton, Letícia Campos Clemente, Edwin Roger Parra Cuentes, Carlos A Torres-Cabala, Eva M Sevick-Muraca
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers 14 (7) (2022)
John C Rasmussen, Sunkuk Kwon, Amanda Pinal, Alexander Bareis, Fred C Velasquez, Christopher F Janssen, John R Morrow, Caroline E Fife, Ron J Karni, Eva M Sevick-Muraca
Assessing lymphatic route of CSF outflow and peripheral lymphatic contractile activity during head-down tilt using near-infrared fluorescence imaging. Physiological reports 8 (4) (2021)
Melissa B Aldrich, John C Rasmussen, Caroline E Fife, Simona F Shaitelman, Eva M Sevick-Muraca
The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors. Cancers 12 (8) (2020)